Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

ared to the same period in 2006 (2006: $117.7 million). Expressed in transaction currencies (REPLAGAL is primarily sold in Euros and Pounds sterling) sales increased by 13% due to higher unit sales in Europe and Canada and the continued roll out of REPLAGAL to new countries, including those in Latin America, with REPLAGAL now approved in 41 countries (including Japan). Exchange rate movements against the US dollar accounted for the remaining 9% increase in sales.

ELAPRASE - Hunter syndrome

Sales for the year to December 31, 2007 were $181.8 million (2006: $23.6 million). Sales growth in 2007 was driven primarily by a full year of sales in the US (ELAPRASE was launched in the US in August 2006), sales in Europe (ELAPRASE was launched in several European markets in the first half of 2007), and pre-approval sales in several Latin American markets. ELAPRASE was approved for sale and marketing in Japan in October 2007 and is now approved for marketing and commercial distribution in 37 countries worldwide.

3. Royalties

Royalty revenue increased to $247.2 million for the year ended December 31, 2007 (2006: $242.9 million).

Royalty Highlights

Royalties to Shire Royalty (1) Growth

Product $M %

3TC 145.3 -4

ZEFFIX 41.0 +18

Other 60.9 +6

Total 247.2 +2

(1) Compared with 2006.

3TC - HIV infection and AIDS Royalties from sales of 3TC for the year to December 31, 2007 were $145.3 million, a decrease of 4% compared to the same period in 2006 (2006: $150.9 million). Excluding favorable foreign exchange movements of 4%, there has been a decline of 8% compared to the same period in 2006.

Shire receive
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... N.J. , July 22, 2014 The Board ... BDX ) has declared a quarterly dividend of 54.5 ... holders of record on September 9, 2014. The indicated annual ... About BD BD is a leading medical technology company ... the world,s most pressing and evolving health needs. Our innovative ...
(Date:7/22/2014)... Terry Baughn, a senior lecturer in mechanical engineering at ... Engineer of the Year by the North Texas section ... ASME has more than 130,000 members in 158 countries ... technology to assist the engineering community, benefiting the world. ... Texas Society of Professional Engineers honors banquet. Baughn retired ...
(Date:7/22/2014)... July 22, 2014 Automated cell culture ... maintenance of cell culture. They allow production of optimum ... of researchers in drug discovery and industries and biopharmaceutical ... mAb production, iPSC research, cryobanking, cell-based assays, and cellular ... risk. , Analysts forecast the Global Cell Culture ...
(Date:7/22/2014)... OHAUS Corporation, a leading worldwide manufacturer ... scales, proudly announces its Explorer line of analytical ... 2014 “Readers' Choice” Award for best balance. ... was voted the best laboratory balance by the ... “excellence in product design and performance for the ...
Breaking Biology Technology:UT Dallas professor receives Engineer of the Year award 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2
... Ganeden Biotech announced the sale of ... brands of probiotic dietary supplements to Schiff ...  Ganeden will also receive royalties on Schiff products containing ... rights to use Ganeden,s probiotic technology, GanedenBC30™, in the ...
... SHENZHEN, China, June 4, 2011 To aid the ... strain in Europe, BGI-Shenzhen and their collaborators at the ... genome assembly result built upon the sequencing data previously ... days. As one of the first genomes assembled using ...
... N.C., June 3, 2011 Recent biopharmaceutical product launches ... the cardiovascular therapeutic area. Faced with a continually evolving ... the biggest role in the current launch environment. ... explores the pivotal success factors and failure points facing ...
Cached Biology Technology:Ganeden Biotech Completes $40 Million Sale of Sustenex® and Digestive Advantage® Probiotic Brands 2Ganeden Biotech Completes $40 Million Sale of Sustenex® and Digestive Advantage® Probiotic Brands 3Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 2Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 3Creating a Road Map for Successful Cardiovascular New Product Launch 2
(Date:7/22/2014)... A probiotic that prevents obesity could be on ... in the gut inhibit weight gain, insulin resistance ... in mice, Vanderbilt University investigators have discovered., "Of ... human," said senior investigator Sean Davies, Ph.D., assistant ... of the negative consequences of obesity in mice, ...
(Date:7/22/2014)... New Rochelle, NY -- Stem cells offer much promise ... transplantation approaches stem cell survival is poor, limiting their ... improve the survival and optimize their therapeutic function after ... BioResearch Open Access , a peer-reviewed journal from Mary ... on the BioResearch Open Access website ...
(Date:7/22/2014)... Curtin University-led research has shown squirrels have adapted to ... just as well, if not better, than their fellow ... Lecturer at Curtin,s Department of Environment & Agriculture, led ... to modify their behaviour in urban environments and prevent ... such as staying on the footpath. , "As ...
Breaking Biology News(10 mins):Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2New York squirrels are nuts about city life 2
... Using satellite data, scientists have produced a first-of-its kind map ... are other local- and regional-scale forest canopy maps, the new ... on one uniform method. The map, based on data ... scientists build an inventory of how much carbon the world,s ...
... Spanish . Two good tips for preventing ... troughs and add chlorine to the water. That,s according ... the agency,s Animal Waste Management Research Unit in Bowling Green, ... a hydrologist at Bowling Green, and other colleagues. Stainless ...
... in French . Men who had a history ... cancer, according to a study carried out by researchers at INRSInstitut ... Montral, and McGill University. The findings, published in the Annals ... had a lower risk of lung cancer while those with a ...
Cached Biology News:First-of-its-kind map details the height of the globe's forests 2Dairy farmers can fight growing disease threat with chlorine and stainless steel 2Asthma and eczema sufferers have a lower risk of developing a cancer 2
biotin-4-fluorescein...
... the LVF-HL, LVF-CUVADPT, FHS-LVF, and the CVD-Diffuse ... low-pass Linear Variable Filters to create the ... center wavelength and adjustable bandpass. Each filter ... blocking band (99.8%). These filters -- ...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Request Info...
Biology Products: